It is our pleasure to announce that the International Workshop on Clinical Pharmacology of HIV Therapy and the International Workshop on Clinical Pharmacology of Hepatitis Therapy will be combined and will be organized 19-21 May 2014 at the W Washington Hotel in Washington DC, USA.
Understanding the clinical pharmacology of antiretroviral therapy is pivotal to designing optimal treatment and prevention strategies for HIV & Hepatitis infection. Drug exposure is significantly influenced by drug interactions, medication taking behavior, and patients’ physiologic and genetic characteristics. These factors are central to determining therapeutic efficacy, failure or toxicity. Despite great progress, many pharmacologic challenges still exist.
The 15th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy will provide a platform for state-of-the-art discussions of current topics fundamental to the optimal use of antiretroviral therapy including drug-drug interactions, pharmacokinetics of investigational agents and existing drugs, pharmacodynamics, drug dosing in special populations, post-marketing surveillance project, and regulatory considerations.
We invite you to attend the 15th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy and encourage you to submit abstracts on your research in this field. Young investigators with an accepted abstract receive a free registration!
We look forward to welcoming you to the workshop in May 2014!
The Program Committee